ClinicalTrials.gov record
Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.
ClinicalTrials.gov ID: NCT02887183
Public ClinicalTrials.gov record NCT02887183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52 Week, Open Label Evaluation of the Effects of Sacubitril/Valsartan (LCZ696) Therapy on Biomarkers, Myocardial Remodeling and Patient-reported Outcomes in Heart Failure With Reduced Left Ventricular Ejection Fraction.
Study identification
- NCT ID
- NCT02887183
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 794 participants
Conditions and interventions
Conditions
Interventions
- LCZ696 (sacubitril/valsartan) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2016
- Primary completion
- Oct 21, 2018
- Completion
- Oct 21, 2018
- Last update posted
- Oct 6, 2021
2016 – 2018
United States locations
- U.S. sites
- 77
- U.S. states
- 25
- U.S. cities
- 69
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35243 | — |
| Novartis Investigative Site | Fort Payne | Alabama | 35967 | — |
| Novartis Investigative Site | Guntersville | Alabama | 35976 | — |
| Novartis Investigative Site | Bakersfield | California | 93308 | — |
| Novartis Investigative Site | Long Beach | California | 90806 | — |
| Novartis Investigative Site | Los Alamitos | California | 90720 | — |
| Novartis Investigative Site | Sylmar | California | 91342 | — |
| Novartis Investigative Site | West Haven | Connecticut | 06516 | — |
| Novartis Investigative Site | Belle Glade | Florida | 33430 | — |
| Novartis Investigative Site | Bradenton | Florida | 34209 | — |
| Novartis Investigative Site | Hollywood | Florida | 33312 | — |
| Novartis Investigative Site | Homestead | Florida | 33030 | — |
| Novartis Investigative Site | Jupiter | Florida | 33458 | — |
| Novartis Investigative Site | Lake Worth | Florida | 334361 | — |
| Novartis Investigative Site | Miami | Florida | 33126 | — |
| Novartis Investigative Site | Miami | Florida | 33133 | — |
| Novartis Investigative Site | Miami | Florida | 33155 | — |
| Novartis Investigative Site | Miami | Florida | 33173 | — |
| Novartis Investigative Site | Port Orange | Florida | 32127 | — |
| Novartis Investigative Site | Wellington | Florida | 33449 | — |
| Novartis Investigative Site | Arlington Heights | Illinois | 60005 | — |
| Novartis Investigative Site | Aurora | Illinois | 60504 | — |
| Novartis Investigative Site | Lombard | Illinois | 60148 | — |
| Novartis Investigative Site | Oak Lawn | Illinois | 60453 | — |
| Novartis Investigative Site | Louisville | Kentucky | 40207 | — |
| Novartis Investigative Site | Owensboro | Kentucky | 42303 | — |
| Novartis Investigative Site | Crowley | Louisiana | 70526 | — |
| Novartis Investigative Site | Shreveport | Louisiana | 71101 | — |
| Novartis Investigative Site | West Monroe | Louisiana | 71291 | — |
| Novartis Investigative Site | Baltimore | Maryland | 21220 | — |
| Novartis Investigative Site | Baltimore | Maryland | 21229 | — |
| Novartis Investigative Site | Columbia | Maryland | 21044 | — |
| Novartis Investigative Site | Boston | Massachusetts | 02114 | — |
| Novartis Investigative Site | Haverhill | Massachusetts | 01830 | — |
| Novartis Investigative Site | Springfield | Massachusetts | 01104 | — |
| Novartis Investigative Site | Kalamazoo | Michigan | 49008 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55415 | — |
| Novartis Investigative Site | Belzoni | Mississippi | 39038 | — |
| Novartis Investigative Site | Jackson | Mississippi | 39209 | — |
| Novartis Investigative Site | Southhaven | Mississippi | 38671 | — |
| Novartis Investigative Site | Bozeman | Montana | 59715 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68506 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68526 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68114 | — |
| Novartis Investigative Site | Nashua | New Hampshire | 03060 | — |
| Novartis Investigative Site | Buffalo | New York | 14215 | — |
| Novartis Investigative Site | Lake Success | New York | 11042 | — |
| Novartis Investigative Site | Potsdam | New York | 13676 | — |
| Novartis Investigative Site | The Bronx | New York | 10461 | — |
| Novartis Investigative Site | Greensboro | North Carolina | 27410 | — |
| Novartis Investigative Site | Hickory | North Carolina | 28601 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigative Site | Hillsboro | Oregon | 97123 | — |
| Novartis Investigative Site | Oregon City | Oregon | 97045 | — |
| Novartis Investigative Site | Portland | Oregon | 97225 | — |
| Novartis Investigative Site | Camp Hill | Pennsylvania | 17011 | — |
| Novartis Investigative Site | Wyomissing | Pennsylvania | 19610 | — |
| Novartis Investigative Site | Yardley | Pennsylvania | 19067 | — |
| Novartis Investigative Site | Simpsonville | South Carolina | 29681 | — |
| Novartis Investigative Site | Germantown | Tennessee | 38138 | — |
| Novartis Investigative Site | Austin | Texas | 78704 | — |
| Novartis Investigative Site | Beaumont | Texas | 77701 | — |
| Novartis Investigative Site | Bryan | Texas | 77802 | — |
| Novartis Investigative Site | Dallas | Texas | 75231 | — |
| Novartis Investigative Site | Houston | Texas | 77081 | — |
| Novartis Investigative Site | Hunstville | Texas | 77340 | — |
| Novartis Investigative Site | McKinney | Texas | 75013 | — |
| Novartis Investigative Site | Sherman | Texas | 75092 | — |
| Novartis Investigative Site | Tomball | Texas | 77375 | — |
| Novartis Investigative Site | Tyler | Texas | 75701 | — |
| Novartis Investigative Site | White River Junction | Vermont | 05009 | — |
| Novartis Investigative Site | Midlothian | Virginia | 23114 | — |
| Novartis Investigative Site | Richmond | Virginia | 23219 | — |
| Novartis Investigative Site | Richmond | Virginia | 23226 | — |
| Novartis Investigative Site | Richmond | Virginia | 23230 | — |
| Novartis Investigative Site | Richmond | Virginia | 23249 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02887183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02887183 live on ClinicalTrials.gov.